Belluscura Past Earnings Performance

Past criteria checks 0/6

Belluscura's earnings have been declining at an average annual rate of -48.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 45% per year.

Key information

-48.5%

Earnings growth rate

-30.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate45.0%
Return on equity-100.2%
Net Margin-1,030.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Belluscura makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9VQ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-19130
31 Mar 241-19130
31 Dec 231-19130
30 Sep 231-14110
30 Jun 231-1090
31 Mar 231-980
31 Dec 221-870
30 Sep 221-880
30 Jun 221-780
31 Mar 221-670
31 Dec 210-550
30 Sep 210-540
30 Jun 210-430
31 Mar 210-320
31 Dec 200-210
31 Dec 190-210
31 Dec 180-110
31 Dec 170-330
30 Nov 160-110

Quality Earnings: 9VQ is currently unprofitable.

Growing Profit Margin: 9VQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9VQ is unprofitable, and losses have increased over the past 5 years at a rate of 48.5% per year.

Accelerating Growth: Unable to compare 9VQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9VQ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21%).


Return on Equity

High ROE: 9VQ has a negative Return on Equity (-100.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies